Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Einstein

Showing results (131-140 of 198) with videos related to

Pageof 20
Sort By:
Gynecologic Oncology|February 19, 2019
Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortiumMark H Einstein, Ntokozo Ndlovu, Jeannette Lee, et al.
British Journal of Cancer|February 14, 2013
Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trialN Colombo, D S McMeekin, P E Schwartz, et al.
Patient Education and Counseling|May 27, 2023
Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: "The land of the unknown"Racquel E Kohler, Jennifer Hemler, Rachel B Wagner, et al.
Genes, Chromosomes & Cancer|August 14, 2019
Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancerAnne Van Arsdale, Nicole E Patterson, Elaine C Maggi, et al.
Gynecologic Oncology|April 9, 2019
The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-upDiane M Harper, Pekka Nieminen, Gilbert Donders, et al.
Journal of Neuro-Oncology|June 28, 2022
Stimulated Raman histology facilitates accurate diagnosis in neurosurgical patients: a one-to-one noninferiority studyEvan H Einstein, Faina Ablyazova, Ashley Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old womanMark H Einstein, Yvette Cruz, Mustafa K El-Awady, et al.
Human Vaccines|December 16, 2010
Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccineTino F Schwarz, Mariëlle Kocken, Tiina Petäjä, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
Serum, Cell-Free, HPV-Human DNA Junction Detection and HPV Typing for Predicting and Monitoring Cervical Cancer RecurrenceAnne Van Arsdale, Olga Mescheryakova, Sonia Gallego, et al.
JCO Global Oncology|August 5, 2021
Assessment of Cervical Cancer Prevention and Treatment Infrastructure in BelizeShane S Neibart, Tiffany A Smith, Jennifer H Fang, et al.
Pageof 20

Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
Gynecologic Oncology|February 19, 2019
Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortiumMark H Einstein, Ntokozo Ndlovu, Jeannette Lee, et al.
British Journal of Cancer|February 14, 2013
Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trialN Colombo, D S McMeekin, P E Schwartz, et al.
Patient Education and Counseling|May 27, 2023
Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: "The land of the unknown"Racquel E Kohler, Jennifer Hemler, Rachel B Wagner, et al.
Genes, Chromosomes & Cancer|August 14, 2019
Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancerAnne Van Arsdale, Nicole E Patterson, Elaine C Maggi, et al.
Gynecologic Oncology|April 9, 2019
The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-upDiane M Harper, Pekka Nieminen, Gilbert Donders, et al.
Journal of Neuro-Oncology|June 28, 2022
Stimulated Raman histology facilitates accurate diagnosis in neurosurgical patients: a one-to-one noninferiority studyEvan H Einstein, Faina Ablyazova, Ashley Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old womanMark H Einstein, Yvette Cruz, Mustafa K El-Awady, et al.
Human Vaccines|December 16, 2010
Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccineTino F Schwarz, Mariëlle Kocken, Tiina Petäjä, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
Serum, Cell-Free, HPV-Human DNA Junction Detection and HPV Typing for Predicting and Monitoring Cervical Cancer RecurrenceAnne Van Arsdale, Olga Mescheryakova, Sonia Gallego, et al.
JCO Global Oncology|August 5, 2021
Assessment of Cervical Cancer Prevention and Treatment Infrastructure in BelizeShane S Neibart, Tiffany A Smith, Jennifer H Fang, et al.
Pageof 20